Valion Bio, Inc. (VBIO) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$5.61M2022: -$8.92M2023: -$8.51M2024: -$5.72M2025: -$7.00M-$7.00M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$7.00M-22.3%
2024-$5.72M+32.7%
2023-$8.51M+4.6%
2022-$8.92M-58.9%
2021-$5.61M